Lam Therapeutics' Series C Round

Lam Therapeutics raised a round of funding on March 30, 2017.

LAM Therapeutics develops precision therapeutics and companion diagnostics for cancer and rare diseases. LAM accelerates drug development by deploying technologies including next-gen sequencing, genom…

Articles about Lam Therapeutics' Series C Round: